4//SEC Filing
IMMUNOGEN INC 4
Accession 0001179110-14-001274
CIK 0000855654operating
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 11:26 AM ET
Size
13.2 KB
Accession
0001179110-14-001274
Insider Transaction Report
Form 4
IMMUNOGEN INCIMGN
Morris Charles Q
Executive VP & CDO
Transactions
- Sale
Common Stock
2014-01-21$17.00/sh−5,535$94,095→ 37,500 total - Exercise/Conversion
Common Stock
2014-01-22$11.93/sh+1,603$19,124→ 39,103 total - Exercise/Conversion
Stock Option (right to buy)
2014-01-21$11.93/sh−5,535$66,033→ 194,465 totalExercise: $11.93From: 2013-11-26Exp: 2022-11-26→ Common Stock (5,535 underlying) - Exercise/Conversion
Common Stock
2014-01-21$11.93/sh+5,535$66,033→ 43,035 total - Sale
Common Stock
2014-01-22$17.00/sh−1,603$27,257→ 37,500 total - Exercise/Conversion
Stock Option (right to buy)
2014-01-22$11.93/sh−1,603$19,124→ 192,862 totalExercise: $11.93From: 2013-11-26Exp: 2022-11-26→ Common Stock (1,603 underlying)
Footnotes (3)
- [F1]Weighted average price of shares sold.
- [F2]The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan executed by the reporting person on August 29, 2013.
- [F3]Exercisable as to 50,000 shares commencing on November 26, 2013, 50,000 shares commencing on November 26, 2014, 50,000 shares commencing on November 26, 2015, and 50,000 shares commencing on November 26, 2016.
Documents
Issuer
IMMUNOGEN INC
CIK 0000855654
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0000855654
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 11:26 AM ET
- Size
- 13.2 KB